Keyword: generics

News

Sandoz Spin-off from Novartis to Start on October 4, 2023

25.09.2023 -

Novartis today confirmed the plan to spin off 100% of its generic drugs arm Sandoz, with trading of the new company’s shares as well as ADRs (American Depositary Receipts...

News

Sandoz in Biosimilars Pact with Just – Evotec Biologics

12.05.2023 -

As Novartis moves toward shedding generics subsidiary Sandoz, which it touts as a global leader in off-patent generic and biosimilar drugs, Sandoz has agreed a multi-year...

News

Novartis to Shutter a Sandoz US Plant

09.09.2022 -

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...

News

Novartis Definitely Plans to Spin off Sandoz

29.08.2022 -

Novartis has finally confirmed definite plans to spin off its generic drugs arm Sandoz.

News

FDA Says Pandemic Hasn’t Hit China’s Drug Exports

08.04.2020 - In early March, the Indian government asserted that the coronavirus epidemic in China was affecting its supply of active pharmaceutical ingredients (APIs), on which it relies for...

Chemistry & Life Sciences

DCAT Week 2019

10.01.2019 - Each year in March, the pharmaceutical manufacturing industry gathers in New York City for DCAT Week, and this year is no exception. DCAT Week ’19, the flagship event of the Drug...

News

FDA Approves Teva’s Generic EpiPen

23.08.2018 - After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...

News

Sanofi Agrees to sell Generics to Advent

12.07.2018 - French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...